News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Simply Wall Street Earnings
Analysts have significantly downgraded their EPS and revenue forecasts for Microvast Holdings, Inc. (MVST) for 2026, now predicting a loss instead of a profit. The consensus price target has also fallen by 18% to US$4.50 due to concerns over weaker financial outlook. The company's revenues are expected to decline, lagging behind the broader industry growth.
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
The Rosen Law Firm is reminding purchasers of Microvast Holdings, Inc. (NASDAQ: MVST) securities from April 1, 2025, to March 16, 2026, about the upcoming September 21, 2026, deadline to serve as lead plaintiff in a securities fraud lawsuit. The lawsuit alleges that Microvast …
Kirby McInerney LLP has filed a securities fraud lawsuit against Microvast Holdings, Inc. (NASDAQ: MVST) on behalf of investors who purchased securities between April 1, 2025, and March 16, 2026. The lawsuit alleges that Microvast made misleading statements regarding its margin targets and its …
The Law Offices of Frank R. Cruz has announced a securities fraud class action lawsuit against Microvast Holdings, Inc. (MVST). The lawsuit alleges that Microvast made false and misleading statements between April 1, 2025, and March 16, 2026, regarding its margin targets and its …
LeMaitre Vascular (LMAT) reported higher Q2 2026 sales and net income, but trimmed its full-year 2026 outlook due to currency headwinds, Middle East export delays, and cardiac allograft supply constraints. Despite these challenges, the company reinforced its growth narrative, though the revised guidance highlights …
SueWallSt has announced a class action lawsuit against Microvast Holdings, Inc. (NASDAQ: MVST) on behalf of investors who purchased securities between April 1, 2025, and March 16, 2026. The lawsuit alleges that Microvast made materially false and misleading statements regarding operational risks, including delays …
Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Microvast Holdings, Inc. (NASDAQ: MVST) on behalf of investors who purchased securities between April 1, 2025, and March 16, 2026. The lawsuit alleges that Microvast made false and misleading statements regarding its …
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty of strategies …
LeMaitre Vascular's stock experienced a 31% drop after missing Q2 2026 expectations due to currency issues, export blockages, and tissue shortages. However, the company demonstrates strong underlying demand with 10% organic sales growth and record-high margins, driven by its fastest-growing product, Artegraft. Despite the …
The Top 5 Analyst Questions From LeMaitre's Q2 Earnings Call LeMaitre's second quarter was marked by strong organic revenue gains, led by robust growth in its Artegraft line and continued expansion across Europe and Asia. However, the quarter fell short of Wall Street's revenue …
Dimensional Fund Advisors LP significantly increased its stake in Microvast Holdings, Inc. (NASDAQ:MVST) by 125.3% during the first quarter, now owning 2.36 million shares worth $3.54 million. This move comes amidst a challenging period for Microvast, which reported a Q2 loss of $0.01 per …
Levi & Korsinsky, LLP reminds investors of Microvast Holdings, Inc. (NASDAQ: MVST) about an upcoming securities class action deadline. The lawsuit alleges that Microvast made misleading statements regarding its financial projections and operational capabilities between April 1, 2025, and March 16, 2026, leading to …
Bernstein Liebhard LLP reminds investors of Microvast Holdings, Inc. (NASDAQ: MVST) about a securities fraud class action lawsuit with a September 21, 2026 deadline to join. The lawsuit alleges that Microvast made false and misleading statements about its business, leading to artificially inflated stock …
Q2 Earnings Highs And Lows: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks Let's dig into the relative performance of LeMaitre (NASDAQ:LMAT) and its peers as we unravel the now-completed Q2 surgical equipment & consumables - specialty earnings …
Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Microvast Holdings, Inc. (NASDAQ: MVST) on behalf of investors who purchased securities between April 1, 2025, and March 16, 2026. The lawsuit alleges that Microvast made false and misleading statements regarding its …
LeMaitre Vascular, Inc. (LMAT), a healthcare sector player specializing in vascular surgery medical devices, shows a potential upside of 39.33% with an average target price of $113.13. Despite trading below its 50-day and 200-day moving averages, the company exhibits strong operational efficiency, a healthy …
The Gross Law Firm has issued an alert to Microvast Holdings, Inc. (MVST) stockholders regarding a securities class action lawsuit. The complaint alleges that Microvast made materially false and/or misleading statements concerning its ability to reach margin targets due to inventory issues and rollout …
Microvast Holdings Inc (MVST) reported its Q2 2026 earnings, highlighting significant European sales growth, which now accounts for 61% of revenue. Despite this, overall revenue decreased by 4.5% year-over-year, and the company posted an adjusted net loss, primarily due to a tariff refund, higher …
Microvast Holdings Inc (MVST) reported its Q2 2026 earnings, highlighting significant European sales growth, which now accounts for 61% of revenue. Despite this, overall revenue decreased by 4.5% year-over-year, and the company posted an adjusted net loss, primarily due to a tariff refund, higher …
Microvast Holdings, Inc. (MVST) reported its Q2 2026 results with revenue of $87.26 million, a 4.5% decrease year-over-year, and a net loss of ($11.99 million), an improvement from ($106.06 million) in the prior-year quarter. Diluted EPS was ($0.03), significantly better than ($0.33) a year …
Microvast Holdings, Inc. (MVST) published its Q2 2026 earnings call presentation on August 10, 2026. The company reported an EPS of -$0.01, missing estimates by $0.01, and revenue of $87.26M, which was down 4.46% year-over-year and missed estimates by $7.14M. This article provides access …
LeMaitre Vascular (LMAT) recently released strong second-quarter 2026 results with increased sales and net income, alongside updated guidance and a reaffirmed cash dividend. Despite positive long-term shareholder returns, recent share price performance has been weak. The stock is considered undervalued by analysts, trading 31.4% …
Quantinno Capital Management LP significantly increased its stake in LeMaitre Vascular, Inc. by 357.4%, acquiring 18,204 additional shares. This brings their total holding to 23,298 shares, valued at approximately $2.54 million. The news comes as LeMaitre Vascular faces mixed analyst sentiment due to missing …
Search by ticker symbol or company name and select a result to open its chart.